COVAX announces new agreement, plans for first deliveries

COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income level, today announced the signing of an advance purchase agreement with Pfizer for up to 40 million doses of the Pfizer-BioNTech vaccine candidate, which has already received WHO emergency use listing. Rollout will commence with the successful negotiation and execution of supply agreements.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Development Research and Development Source Type: news